Learn More
Medchemexpress LLC Benzoic acid, 4-[4-[[(3R)-1-butyl-3-[(R)-cyclohexylhydroxymethyl]-2,5-dioxo-1,4,9-triazaspiro [5.5]undec-9-yl]methyl]phenoxy]-, hydrochloride (1:1) | 461023-63-2 | 99.9% | 614.17 | 1 ML

Supplier: Medchemexpress LLC HY17450A10MM/1ML
Aplaviroc hydrochloride, an SDP derivative, is a potent CCR5 antagonist. It exhibits strong activity against various HIV-1 strains, including wild-type and multidrug-resistant variants, by binding to CCR5 with high affinity and inhibiting gp120/CD4 binding. This compound has been shown to suppress R5 HIV-1 viremia in in vivo models.
- Potent activity against three wild-type R5 HIV-1 strains (HIV-1Ba-L, HIV-1JRFL, and HIV-1MOKW).
- Substantially more potent than previously published CCR5 inhibitors.
- Suppresses infectivity and replication of two HIV-1MDR variants.
- Binds to CCR5 with high affinity.
- Potently blocks rgp120/sCD4 binding to CCR5.
- Exerts potent anti-R5 human immunodeficiency virus type 1 effects in a novel AIDS mouse model.
- Suppresses R5 HIV-1 viremia in hu-PBMC-NOG mice.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.